Ronald Litman
Nurse Practitioner · Marion, OHNPI 1578059630
Payments from drug & device makers
Across 200 payments — averaging $37.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascensia Diabetes Care US Inc.$2K
- Senseonics, Incorporated$2K
- AbbVie$1K
- AstraZeneca$857
- Novo Nordisk$250
- Lilly USA, LLC$245
- plus $1K from 19 others
What the payments were for
- Consulting fees$1,96026%
- Speaking & faculty fees$1,71423%
- Food & beverage$3,91052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascensia Diabetes Care US Inc. | 7 | $1,982 |
| Senseonics, Incorporated | 4 | $1,714 |
| AbbVie | 56 | $1,074 |
| AstraZeneca | 30 | $857 |
| Novo Nordisk | 16 | $250 |
| Lilly USA, LLC | 10 | $245 |
| Johnson & Johnson | 6 | $210 |
| GSK | 13 | $191 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $171 |
| Pfizer | 11 | $165 |
| Vanda Pharmaceuticals Inc. | 5 | $108 |
| Amgen | 6 | $104 |
| Otsuka America Pharmaceutical, Inc. | 6 | $96 |
| Corcept Therapeutics | 5 | $94 |
| Astellas Pharma US Inc | 5 | $83 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Exact Sciences | 2 | $37 |
| Dexcom, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,584 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 21 | $61,906 |
| EliquisApixaban | 85 | $52,415 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 13 | $51,178 |
| OzempicSemaglutide | 39 | $46,404 |
| BriviactBrivaracetam | 40 | $42,145 |
| RexultiBrexpiprazole | 23 | $25,718 |
| MyrbetriqMirabegron | 39 | $16,891 |
| TrulicityDulaglutide | 16 | $14,674 |
| JardianceEmpagliflozin | 32 | $14,268 |
| JanuviaSitagliptin Phosphate | 11 | $11,789 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 51 | $10,818 |
| Spiriva RespimatTiotropium Bromide | 13 | $10,159 |
| FarxigaDapagliflozin Propanediol | 23 | $9,636 |
| BrilintaTicagrelor | 21 | $8,050 |
| LinzessLinaclotide | 12 | $7,417 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $171 | $61,90621 claims |
| PfizerEliquis | $165 | $52,41585 claims |
| Novo NordiskOzempic | $250 | $46,40439 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $96 | $25,71823 claims |
| AstraZenecaFarxiga, Brilinta | $857 | $17,68644 claims |
| Astellas Pharma US IncMyrbetriq | $83 | $16,89139 claims |
| Lilly USA, LLCTrulicity | $245 | $14,67416 claims |
| AbbVieLinzess | $1,074 | $7,41712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Marion
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.